|
|
|
|
| LEADER |
02388nam a2200217 a 4500 |
| 001 |
1807823 |
| 005 |
20171111234553.0 |
| 008 |
120117s2012 njua sb 001 0 eng d |
| 020 |
|
|
|z 9781118149652 (cloth)
|
| 040 |
|
|
|a CaPaEBR
|z 9781118347836 (e-book)
|
| 050 |
1 |
4 |
|a RB56
|b .D37 2012eb
|
| 100 |
1 |
|
|a Dasgupta, Amitava,
|d 1958-
|
| 245 |
1 |
0 |
|a Resolving erroneous reports in toxicology and therapeutic drug monitoring
|b a comprehensive guide /
|c Amitava Dasgupta.
|
| 260 |
|
|
|a Hoboken, N.J. :
|b John Wiley & Sons,
|c c2012.
|
| 300 |
|
|
|a viii, 457 p. :
|b ill.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a An introduction to tests performed in toxicology laboratories and methodologies available for such testings -- Challenges in drugs of abuse testing -- False positive results in immunoassays for drugs of abuse testing -- True positive drugs of abuse test results due to prescription and non-prescription drugs -- When toxicology report is negative in a suspected overdosed patient : the world of designer drugs -- Abuse of magic mushroom, peyote cactus and solvent : no readily available laboratory tests -- False positive alcohol tests using breath analyzers and automated analyzers -- Role of laboratory in detecting other poisoning including pesticides, ethylene glycol, and methanol -- Poisoning with warfarin and superwarfarin : what laboratory can do? -- Plant poisoning and clinical laboratory -- Sources of erroneous results in therapeutic drug monitoring due to pre-analytical errors, high bilirubin, hemolysis, and heterophilic antibody -- Interferences in immunoassays used for digoxin monitoring -- Interferences in immunoassays used for monitoring anticonvulsants and usefulness of monitoring free anticonvulsants in certain patients -- Interferences in immunoassays used for monitoring tricyclic antidepressant -- Therapeutic drug monitoring of immunosuppressant drugs : limitations of immunoassays and need for chromatographic methods -- Effect of drug-herb interactions on therapeutic drug monitoring -- Pharmacogenomics and toxicology laboratory -- Approaches for eliminating interference/discordant specimen in therapeutic drug monitoring and drugs of abuse testing.
|
| 650 |
|
0 |
|a Drug monitoring.
|
| 710 |
2 |
|
|a ebrary, Inc.
|
| 856 |
4 |
0 |
|u http://site.ebrary.com/lib/ucy/Doc?id=10580148
|
| 952 |
|
|
|a CY-NiOUC
|b 5a045a826c5ad14ac1ed5224
|c 998a
|d 945l
|e -
|t 1
|x m
|z Books
|
